乐家老铺品牌怎么样 申请店铺

我要投票 乐家老铺在中医保健行业中的票数:533 更新时间:2025-06-16
乐家老铺是哪个国家的品牌?「乐家老铺」是 南京同仁堂药业有限责任公司 旗下著名品牌。该品牌发源于江苏,由创始人浩健在1998期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力乐家老铺品牌出海!将品牌入驻外推网,定制乐家老铺品牌推广信息,可以显著提高乐家老铺产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

乐家老铺怎么样

南京同仁堂药业有限责任公司位于美丽的雨花台风景区西麓,是南京市唯一一家以现代科技生产古方传统品种和综合新剂型,集科、工、贸为一体的中药企业,1995年被国家内贸部授予“中华老字号”、2006年被商务部再次授予全国第一批“中华老字号”的荣誉称号。

南京同仁堂药业有限责任公司历史悠久,其前身是北平同仁堂京都乐家老铺南京分号,于1926年在南京开业,1955年更名为公私合营南京同仁堂国药号股份有限公司,1957年定名为南京同仁堂制药厂。1998年,改制组建南京同仁堂药业有限责任公司。

2000年按国家行业管理的要求,公司投巨资进行GMP改造,引进了一流的片剂、丸剂、胶囊剂、颗粒剂、口服液等剂型的生产线。2002年11月,九个剂型一次性通过国家GMP认证,开创了全国中成药行业GMP认证之先河。技术改造,加快了企业科技发展步伐,使中成药的技术含量得到提升。2009年公司获得国家“高新技术企业”的殊荣。

在继承和发扬传统精萃“大活络丸”、“牛黄清心丸”、“石斛夜光丸”、“乌鸡白凤丸”等品质高、疗效好的传统产品外,企业相继自行研制、开发了一批颇具特色的新产品。有国内首创治疗泌尿系统结石症的特效中成药、荣获国家银质奖、全国用户满意产品、江苏省名牌产品称号的“排石颗粒”;列为国家中药保护品种、获江苏省名牌产品、江苏省高新技术产品称号的治疗乳腺小叶增生的“乳宁颗粒”、对病毒性感冒疗效显著的“羚羊感冒口服液”及“止嗽化痰颗粒”;国内首创且独家生产的抗结核纯中药制剂“优福宁胶囊”;治疗妇科出血症有特效的“血安胶囊”;治疗胆结石、胆囊炎的“胆舒排石颗粒”和专治乳糜尿的“水蜈蚣颗粒”等,良好的产品结构为企业的发展注入了无限的活力。

“炮制虽繁,必不敢省人工;品味虽贵,必不敢减物力”,这是同仁堂传承百年的古训;“同修仁德、济世养生”、“修合无人见,存心有天知”则是企业奉行的准则。公司生产产品在历年的市场抽查中,合格率均为100%,企业多次荣获省、市优秀管理企业、文明单位、南京市先进集体的荣誉称号。2008年,公司“乐家老铺”注册商标获“江苏省著名商标”荣誉称号;2009年,该商标又获得“驰名保护”的荣誉称号。

企业将以老字号品牌为核心,在传承中创新,在创新中发展,让百年老企业,不断焕发勃勃生机。

Nanjing Tongrentang Pharmaceutical Co., Ltd. is located at the West foot of the beautiful Yuhuatai scenic spot. It is the only traditional Chinese medicine enterprise in Nanjing that integrates science, industry and trade with modern science and technology to produce traditional Chinese medicine varieties and comprehensive new dosage forms. In 1995, it was awarded "China Time-honored Brand" by the Ministry of internal trade of the people's Republic of China. In 2006, it was awarded the first batch of "China Time-honored Brand" by the Ministry of Commerce of the people's Republic of China 。 Nanjing Tongrentang Pharmaceutical Co., Ltd. has a long history. Its predecessor is the Nanjing Branch of lega old shop in Kyoto, Tongrentang, Peking. It was opened in Nanjing in 1926. In 1955, it was renamed as the public-private joint venture Nanjing Tongrentang National Pharmaceutical Co., Ltd. and in 1957, it was named Nanjing Tongrentang pharmaceutical factory. In 1998, Nanjing Tongrentang Pharmaceutical Co., Ltd. was restructured. In 2000, according to the requirements of national industry management, the company invested heavily in GMP transformation and introduced first-class production lines of tablets, pills, capsules, granules, oral liquids and other dosage forms. In November 2002, nine dosage forms passed the national GMP certification at one time, creating a precedent for GMP certification in the Chinese patent medicine industry. Technological transformation has accelerated the development of science and technology of enterprises and improved the technical content of Chinese patent medicine. In 2009, the company won the national "high tech enterprise" award. In addition to inheriting and carrying forward the traditional products with high quality and good curative effect, such as "Da Huo Luo Wan", "Niu Huang Qing Xin Wan", "Dendrobium night light Wan" and "Wuji Bai Feng Wan", the enterprises have developed and developed a number of distinctive new products one after another. There are special Chinese patent medicine for urolithiasis, Paishi granule, which has won the national silver award, the national user satisfaction product and the title of famous brand product in Jiangsu Province. It is listed as the national traditional Chinese medicine protection variety, the famous brand product in Jiangsu Province, and the high-tech product in Jiangsu Province. It is the "runing Granule" for the treatment of breast lobular hyperplasia, and the "antelope" which has significant effect on viral cold Yangganmao oral liquid and Zhisou Huatan granules, the first and exclusive antituberculous pure Chinese medicine preparation "youfuning capsule", the special "Xuean capsule" for the treatment of gynecopathy, the "Danshu Paishi granules" for the treatment of gallstones and cholecystitis, and the "shuicentipede granules" for the treatment of chyluria, etc. good product structure has injected infinite vitality into the development of the enterprise 。 "Although the processing is complex, it will not be able to save labor; although the taste is expensive, it will not be able to reduce material resources". This is the ancient motto of Tongrentang that has been passed down for a hundred years; "cultivating benevolence and morality, helping the world and keeping health", "cultivating and combining without people's eyes, knowing with heart" is the principle that the enterprise pursues. In the market spot check of the company's products over the years, the qualified rate is 100%. The company has won the honorary titles of provincial and municipal excellent management enterprise, civilized unit and Nanjing advanced collective for many times. In 2008, the registered trademark of the company "lejialaopu" won the honorary title of "famous trademark of Jiangsu Province"; in 2009, the trademark also won the honorary title of "well-known protection". The enterprise will take the old brand as the core, innovate in the inheritance and develop in the innovation, so that the hundred year old enterprise will continue to glow with vitality.

本文链接: https://brand.waitui.com/3da29db34.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

中信建投:下半年A股市场震荡中枢有望逐渐上移,蓄势待起

36氪获悉,中信建投发布2025下半年A股投资策略研报称,2025年下半年,在弱美元趋势、资本市场政策支持和流动性环境整体性改善的推动下,A股市场震荡中枢有望逐渐上移,蓄势待起。市场向上的关键在于:财政发力、中美降息、通缩改善、新兴产业发展。配置上建议继续以红利资产作为核心底仓品种,积极参与以“新机智药”为代表的新赛道投资机遇。行业重点关注:创新药、服务消费(美容、宠物、零售、社服)、AI(AI Agent、AI应用)、人形机器人、银行、非银、交运、公用事业、有色金属等。

2小时前

股票策略业绩“打头阵”,私募青睐科技与医药板块

股票策略私募赚钱效应持续显现。私募排排网数据显示,截至5月底,股票策略私募证券投资基金今年以来的平均收益接近5%,正收益占比超过70%,超400只产品年内收益超过20%。数据显示,截至5月底,有业绩记录的12843只私募证券投资基金,今年以来平均收益为4.34%。分策略来看,股票策略业绩领跑。私募加码权益类资产,科技与医药板块明显更受青睐。Choice数据显示,截至6月14日,5月以来私募“组团”调研了半导体、医疗企业、通用设备等行业的头部企业,如安集科技、百济神州、盛美上海等。(上证报)

2小时前

三叶草生物:与国光生技终止合作

36氪获悉,三叶草生物在港交所公告,公司于2023年2月20日公告,与国光生物科技股份有限公司(简称“国光生技”)订立独家协议,据此三叶草生物,包括但不限于在中国大陆分销四价季节性流感疫苗。鉴于市场状况出现重大变化,公司行使独家协议项下之单方终止权,公司已于2025年6月15日向国光生技发出通知以终止独家协议,自2025年6月30日生效。该终止生效后,公司与国光生技将停止该合作,且公司将不再于中国大陆分销四价季节性流感疫苗。董事会认为,该终止不会对公司的运营产生重大不利影响。公司将继续致力于推进自研专有的呼吸道合胞病毒(RSV)候选疫苗SCB-1019在RSV疫苗重复接种和作为相关呼吸道联合疫苗一部分的研究应用开发。

2小时前

光学AI处理器可高效准确分类无线信号

据最新一期《科学进展》杂志报道,美国麻省理工学院团队开发出一种专为无线信号处理而设计的全新人工智能(AI)硬件加速器。这种光学处理器能以光速进行机器学习运算,可在数十纳秒内完成无线信号分类,且准确率可达95%。其可广泛应用于高性能计算场景,远胜现有的数字AI加速器。(科技日报)

2小时前

脑机接口新系统成失语者“数字声带”

美国加州大学戴维斯分校团队开发出一种研究性脑机接口,有望帮助因神经系统疾病而失去说话能力的人重新“发声”。这项成果发表在最新一期《自然》杂志上,展示了该技术如何在人尝试说话时,立即将大脑活动转化为语音,从而创建出一种“数字声带”。这项技术已在一名患有肌萎缩侧索硬化症(俗称“渐冻症”)的参与者身上测试成功。他通过植入式脑机接口,借助计算机与家人实时对话,不仅可以控制语调,还能唱出简单的旋律。(科技日报)

2小时前

本页详细列出关于乐家老铺的品牌信息,含品牌所属公司介绍,乐家老铺所处行业的品牌地位及优势。
咨询